| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19
|
McElvaney, Oliver J.
|
|
|
3 |
4 |
p. 233-248.e6
|
article
|
| 2 |
Does HIV-1 virulence matter in the ART era?
|
Lewitus, Eric
|
|
|
3 |
4 |
p. 217-219
|
article
|
| 3 |
Integrating functional genomics with genetics to understand the biology of ALS and FTD
|
Cruchaga, Carlos
|
|
|
3 |
4 |
p. 226-227
|
article
|
| 4 |
Quantity versus quality: Keys to adoptive cell therapy success in breast cancer
|
Lou, Emil
|
|
|
3 |
4 |
p. 220-222
|
article
|
| 5 |
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
|
McMahan, Katherine
|
|
|
3 |
4 |
p. 262-268.e4
|
article
|
| 6 |
The User Experience of AI
|
Huang, Erich S.
|
|
|
3 |
4 |
p. 228-232
|
article
|
| 7 |
Unveiling the mechanisms of hematopoietic stem cell transplantation: Balancing cell senescence and proliferation in cancer and beyond
|
Monsour, Molly
|
|
|
3 |
4 |
p. 223-225
|
article
|
| 8 |
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
|
Miyamoto, Sho
|
|
|
3 |
4 |
p. 249-261.e4
|
article
|
Journal description